Skip to content
value.today
CapForce Inc. logo

CapForce Inc.

CFOR
$4 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$30 M
For year ending December-2025
Net income
$24 M
78.2% margin
SEC filing
Employees
—

CapForce Inc. in brief

CapForce Inc. is a listed company in the Diagnostics and Research industry, based in the USA. Its last known market value was $4 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $30 M and a net profit of $24 M, about 78 cents of profit for every dollar of sales. Its shares trade under the symbol CFOR (OTC Markets Group).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

CapForce Inc. timeline

1 events, 2015
  1. 2015
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of CapForce Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$12 M$25 M$37 M$50 M20202021202220232024

World rank over time

▼ down 5,588 places since 2020
2020-01-01: #27034#27,03420202021-01-01: #20968#20,96820212022-01-07: #27376#27,37620222022-12-25: #32151#32,15120222023-07-30: #33648#33,64820232024-01-05: #32622#32,6222024

Rank in USA: #4,755 (Jan 2020) · #4,106 (Jan 2021) · #5,048 (Jan 2022) · #5,674 (Dec 2022) · #5,700 (Jul 2023) · #4,656 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
78.2%
Operating margin
79.6%
Return on equity
74.1%
Liabilities / assets
16.3%
Net debt
$-3M
Revenue growth
+480.8%
R&D / revenue
0.0%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue $3M, net income $-13M$3MFY18Fiscal year ending Dec 2019: revenue $4M, net income $-12M$4MFY19Fiscal year ending Dec 2020: revenue $4M, net income $-26M$4MFY20Fiscal year ending Dec 2021: revenue $4M, net income $-35M$4MFY21Fiscal year ending Dec 2022: revenue $3M, net income $-37M$3MFY22Fiscal year ending Dec 2023: revenue $3M, net income $-33M$3MFY23Fiscal year ending Dec 2024: revenue $5M, net income $12M$5MFY24Fiscal year ending Dec 2025: revenue $30M, net income $24M$30MFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$30M+480.8%$24M$24M78.2%
Dec 2024$5M+52.0%$0M$12M230.6%
Dec 2023$3M+31.0%$-31M$-33M-955.3%
Dec 2022$3M-39.4%$-35M$-37M-1428.4%
Dec 2021$4M+2.4%$-23M$-35M-807.7%
Dec 2020$4M+20.3%$-23M$-26M-622.6%
Dec 2019$4M+18.6%$-12M$-12M-355.7%
Dec 2018$3M—$-13M$-13M-453.2%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-1M$0M$-1M$2.32—
Dec 2024$-5M——$2.30—
Dec 2023$-14M$1M$-15M$-41.47—
Dec 2022$-20M$1M$-21M$-152.70—
Dec 2021$-21M$2M$-23M$-22.89—
Dec 2020$-23M$0M$-24M$-1.66—
Dec 2019$-12M$0M$-12M$-7.70—
Dec 2018$-11M$0M$-11M$-44.49—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Sep 2024: revenue —, net income $9M—Sep ’24Three months to Dec 2024 (from the annual report): revenue —, net income $4M—Dec ’24Three months to Mar 2025: revenue —, net income $-0M—Mar ’25Three months to Jun 2025: revenue $4M, net income $4M$4MJun ’25Three months to Sep 2025: revenue —, net income $-1M—Sep ’25Three months to Dec 2025 (from the annual report): revenue —, net income $21M—Dec ’25Three months to Mar 2026: revenue —, net income $-1M—Mar ’26Three months to Jun 2026: revenue $50M, net income $42M$50MJun ’26

Latest quarter to Jun 2026: revenue $50M (+1150.0% on a year earlier), net income $42M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

Annual results

Revenue
$30 M
Operating income
$24 M
Net income
$24 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$38 M
Total liabilities
$6 M
Total equity
$32 M

As of December-2025

Insider trading at CapForce Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$0
0 sales, 0 insiders
Net, 12 months
$0
open market only
Insiders on file
6
since
CapForce Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Low Yu Jie EthanDirectorGrant or award+5,555——34,126Form 4
filed Yee Gillian Tan RouCorporate SecretaryGrant or award+2,778——18,403Form 4
filed Chua Kok Hoe VictorDirectorGrant or award+5,555——34,126Form 4
filed Wong Poh Yin ConstanceDirectorGrant or award+5,555——34,126Form 4
filed Mohd Azham AzudinCOOGrant or award+5,555——36,805Form 4
filed Lim Zhao Qi KenDirectorGrant or award+5,555——34,126Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: CapForce Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
87
0.0% of shares · 1 days to cover
Shares sold short, last 24 reportsAll stocks →

Stock splits: 1-for-20 reverse split ; 1-for-25 reverse split

Fails to deliver

  • : 78 shares at $24.50
  • : 348 shares at $23.99
  • : 1,137 shares at $15.70
  • : 4,023 shares at $14.00
  • : 1,300 shares at $6.40

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

CapForce Inc. scorecard#

Passes 10 of the 14 checks that could be worked out: strongest in growth (6 of 6), weakest in profitability (4 of 5). Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth6 of 6
    • ✓Revenue grew in the newest year480.8%Revenue up 480.8% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years126.2%126.2% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median126.2%126.2% a year against Diagnostics and Research's median of 3.6% (64 companies).
    • ✓Earnings per share grew in the newest year2.32 vs 2.30Diluted EPS 2.32 in fiscal 2025 against 2.30 the year before (report's currency).
    • ✓Net income higher than five years earlier$24 M$24 M in fiscal 2025 against -$26 M in 2020.
    • ✓Revenue rose in at least four of the last five years4 of 5Revenue rose in 4 of the five years to fiscal 2025.
  • Profitability4 of 5
    • ✓Profitable in the newest year$24 MNet income $24 M in fiscal 2025.
    • ✗Profitable in each of the last five years2 of 5Profitable in 2 of the five years to fiscal 2025.
    • ✓Operating margin above its peers' median79.6%79.6% against Diagnostics and Research's median of -2.4% (66 companies).
    • ✓Return on equity above 15%120.4%120.4% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier79.6%79.6% in fiscal 2025 against -1324.5% in 2022.
  • Financial health0 of 2
    • ✗Short-term assets cover short-term liabilities0.2×Current ratio 0.22 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year94.0%Diluted shares up 94.0% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.

Worked out from the statements as filed (sec), the medians of Diagnostics and Research, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from CapForce Inc.'s statements, beside the median of Diagnostics and Research.

CapForce Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin79.6%-2.4%
Net margin78.2%-3.6%
Return on equity120.4%-5.4%
Revenue growth, 3 years a year126.2%3.6%
Revenue growth480.8%6.6%
Free cash flow margin-4.1%4.7%

2of 7on the Piotroski tests of financial strength

  • Free cash flow was negative: -$1 million.
  • Only -5% of net income arrived as cash from operations.
  • The share count rose 94.0% in the year.
  • Liabilities due within a year exceed current assets (current ratio 0.22).

CapForce Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

CapForce Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2016to Dec 31, 2016
Income statement
Revenue305.23.42.64.34.23.52.93.24.0
Cost of revenue——3.13.32.3———1.61.7
Research and development0.00.04.78.21110.05.15.76.98.6
Selling and marketing0.00.22.84.33.73.11.51.52.85.5
General and administrative3.14.58.18.99.98.86.37.16.76.6
Total costs and expenses6.24.93437282716161823
Operating income240.3−31−35−23−23−12−13−15−19
Interest expense and finance costs0.00.01.83.34.83.40.20.20.20.1
Other non-operating income (expense)0.412−1.9−2.7−11−3.4−0.2−0.2−0.2−0.2
Income before tax2412−33−37−35−26−12−13−15−19
Income tax0.80.2——0.00.10000
Net income including minority interests2412−33—−35−26−12−13−15—
Net income attributable to shareholders2412−33−37−35−26−12−13−15−19
Earnings per share, basic2.332.44-41.47-152.70r-22.89r-1.66-7.70-44.49r-9.80-27.59r
Earnings per share, diluted2.322.30-41.47-152.70r-22.89r-1.66-7.70-44.49r-9.80-27.59r
Shares, weighted average (basic)104.70.80.2r1.8—————
Shares, weighted average (diluted)105.20.80.2r1.8r161.60.3r1.60.7r
Balance sheet
Cash and cash equivalents0.51.31.27.436132.74.61.84.1r
Receivables0.20.00.10.51.20.70.60.40.80.5
Inventory———3.64.73.2r0.50.50.50.7
Other current assets0.21.30.31.41.31.40.40.30.30.3
Current assets1.02.61.61140176.75.83.55.7
Property, plant and equipment0.91.1—3.54.03.30.11.20.80.8
Right-of-use (leased) assets0.80.8—1.51.82.11.00——
Goodwill———07.58.00.60.60.60.6
Other intangible assets0.1——7.415170.81.11.41.6
Total assets389.91.9267250109.06.69.0
Accounts payable1.10.20.10.41.31.91.11.61.72.2
Debt due within a year——117.0150.70.4———
Current liabilities4.60.61111207.44.94.44.85.3
Long-term debt———4.9——————
Lease liabilities (non-current)1.61.82.02.63.01.50.50——
Total liabilities6.22.5131830296.15.65.25.8
Retained earnings−270−294−305−273−236−201−175−162−149−133
Shareholders' equity327.4−127.641214.33.31.43.2
Total liabilities and equity389.91.9267250109.06.69.0
Shares outstanding10101.30.3r2.3r255.60.4r2.31.0r
Cash-flow statement
Depreciation and amortization0.20.21.31.62.72.30.90.70.70.7
Share-based compensation0.30.60.21.00.90.30.40.90.90.9
Cash from operating activities−1.2−4.9−14−20−21−23−12−11−14−17
Capital expenditure−0.1—−0.8−0.6−2.0−0.1−0.0−0.1−0.3−0.1
Acquisitions, net of cash acquired—————−1.3————
Cash from investing activities−0.0—−0.8−0.6−2.0−1.1−2.5−0.1−0.3−0.1
Debt issued——12—9.11.90.5———
Debt repaid——−3.9−11−0.4−1.0−0.8−0.4−1.3−0.2
Shares issued——123.1r1.5164.83.4r3.84.4
Cash from financing activities0.55.08.4−6.7473412141214
Exchange-rate effect on cash————————−0.00.0
Change in cash−0.80.2−6.5−292311−1.82.6−2.3−3.7
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Acquisitions and funding#

8 private funding rounds before listing

Private share sales · funding history

Private share sales of CapForce Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Oct 2022$3 MPrivate placement after listing$2 to $10 million1equity, optionsSEC
Feb 2021$25 MPrivate placement after listing$10 to $50 million1equity, optionsSEC
Nov 2020$10 MPrivate placement after listing$2 to $10 million1equity, optionsSEC
May 2016$7 MPrivate placement after listing$2 to $10 million10equity, optionsSEC
Jul 2015$3 MIssued in a merger or acquisition$2 to $10 million4equitySEC
Feb 2015$1 MNo. 8Under $2 million9debt, optionsSEC
Jul 2014$1 MNo. 7Under $2 million4debt, optionsSEC
Dec 2013$4 MNo. 6$2 to $10 million29debt, optionsSEC
Mar 2012$6 MNo. 5$2 to $10 million28equity, optionsSEC
Nov 2011$4 MNo. 4$2 to $10 million27debt, optionsSEC
Sep 2010$12 MNo. 3$10 to $50 million33equitySEC
Mar 2010$4 MNo. 2$2 to $10 million13debt, optionsSEC
Nov 2009$4 MNo. 1$2 to $10 million14debt, optionsSEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

How CapForce Inc. compares in Diagnostics and Research

  • Revenue$30 M · higher than 23% of 123
  • Net margin78.2% · highest of 112
  • Revenue growth480.8% · higher than 99% of 89

Peer comparison · Diagnostics and Research

CompanyMarket capP/ENet marginRev. growth
CapForce Inc.🇺🇸$4 M—78.2%+480.8%
Thermo Fisher Scientific Inc.🇺🇸$253.8 B35.9×14.9%+3.9%
Danaher Corporation🇺🇸$166.7 B38.5×16.9%+2.9%
WuXi AppTec Co., Ltd.🇨🇳$70.4 B25.4×42.1%—
Natera, Inc.🇺🇸$58.7 B—-5.7%+35.9%
Siemens Healthineers AG🇩🇪$52.8 B22.9×8.7%—
Lonza Group AG🇨🇭$51.9 B—-4.2%—
Agilent Technologies, Inc.🇺🇸$48.8 B33.9×19.5%+6.7%
IQVIA Holdings Inc.🇺🇸$45.1 B32.4×8.1%+5.9%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 16, 2026

Figures from SEC filing, value.today research; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at CapForce Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show CapForce Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about CapForce Inc.? Suggest a correction